Journal
IMMUNITY
Volume 32, Issue 2, Pages 175-186Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2010.02.004
Keywords
-
Categories
Funding
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Ask authors/readers for more resources
Natural killer (NK) cell cytotoxicity toward target cells depends on synergistic coactivation by NK cell receptors such as NKG2D and 2B4. How synergy occurs is not known. Synergistic phosphorylation of phospholipase PLC-gamma 2, Ca2+, mobilization, and degranulation triggered by NKG2D and 2B4 coengagement were blocked by Vav1 siRNA knockdown, but enhanced by knockdown of c-CbI. c-CbI inhibited Vav1-dependent signals, given that c-CbI knockdown did not rescue the Vav1 defect. Moreover, c-CbI knockdown and Vav1 overexpression each circumvented the necessity for synergy because NKG2D or 2134 alone became sufficient for activation. Thus, synergy requires not strict complementation but, rather, strong Vav1 signals to overcome inhibition by c-CbI. Inhibition of NK cell cytotoxicity by CD94NKG2A binding to HLA-E on target cells was dominant over synergistic activation, even after c-CbI knockdown. Therefore, NK cell activation by synergizing receptors is regulated at the level of Vav1 by a hierarchy of inhibitory mechanisms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available